Radiolabeling and biological evaluation of I-125-Necitumumab for EGFR-targeted SPECT imaging
文献类型:期刊论文
作者 | Lu, XM; Li, X; Peng, Y; Wang, T; Li, DN; Jia, LN; Zhang, L |
刊名 | JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
![]() |
出版日期 | 2020 |
卷号 | 323期号:1页码:83-89 |
关键词 | NECITUMUMAB CANCER EXPRESSION CETUXIMAB ANTIBODY IMPACT TUMOR |
ISSN号 | 0236-5731 |
DOI | 10.1007/s10967-019-06933-8 |
文献子类 | 期刊论文 |
英文摘要 | Radiolabeled epidermal growth factor receptor (EGFR) targeted antibody could be used for imaging EGFR expressing cancer. In this study, the SPECT probe I-125-Necitumumab were synthesized and evaluated for SPECT imaging of non-small cell lung cancer (NSCLC). In vivo biodistribution study indicated that I-125-Necitumumab was cleared rapidly in most organs and tissues. Though the tumor expressed a relatively high level of EGFR, however SPECT images showed no obvious uptake in the tumors. Therefore, we considered that I-125-Necitumumab was not suitable for EGFR-targeted NSCLC SPECT imaging. |
语种 | 英语 |
源URL | [http://ir.sinap.ac.cn/handle/331007/33100] ![]() |
专题 | 上海应用物理研究所_中科院上海应用物理研究所2011-2017年 |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Appl Phys SINAP, Shanghai 201800, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China |
推荐引用方式 GB/T 7714 | Lu, XM,Li, X,Peng, Y,et al. Radiolabeling and biological evaluation of I-125-Necitumumab for EGFR-targeted SPECT imaging[J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY,2020,323(1):83-89. |
APA | Lu, XM.,Li, X.,Peng, Y.,Wang, T.,Li, DN.,...&Zhang, L.(2020).Radiolabeling and biological evaluation of I-125-Necitumumab for EGFR-targeted SPECT imaging.JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY,323(1),83-89. |
MLA | Lu, XM,et al."Radiolabeling and biological evaluation of I-125-Necitumumab for EGFR-targeted SPECT imaging".JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY 323.1(2020):83-89. |
入库方式: OAI收割
来源:上海应用物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。